🇺🇸 FDA
Pipeline program

TAK-137 5 mg tablet, TAK-137 placebo tablet

TAK-137/CPH-001

Phase 1 small_molecule terminated

Quick answer

TAK-137 5 mg tablet, TAK-137 placebo tablet for Healthy Japanese Adult Male is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Healthy Japanese Adult Male
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials